Symbiomix Therapeutics
Biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections than can have serious health consequences.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD205m (Public information from Oct 2017)
Newark New Jersey (HQ)
Authorizing premium user...